CLINICAL_TRIALS
trial_result
· 2009-05-06
Clinical Trial Update: Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection [Phase 3]
Summary
Phase 3 pediatric trial of famciclovir for herpes simplex virus infection in children aged 1 to 12 years has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Herpes Simplex | Phase 3 | Status: COMPLETED | Results posted: 2009-05-06